Molecular Oncology : Impact Factor & More
eISSN: 1878-0261pISSN: 1574-7891
Open AccessShare this on:
Key Metrics
CiteScore 
10.4
Eigenfactor
0.01 - 0.05
H-Index
105
Impact Factor
5 - 10
SJR
Q1Genetics
SNIP
1.38
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Molecular Oncology
Molecular Oncology Journal Specifications
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 3600 |
| Publication Time | 10 |
| Editorial Review Process | Open peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Federation of European Biochemical Societies |
| Frequency | Monthly |
| Publication Start Year | 2007 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Molecular Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Molecular Oncology
Plasma extrachromosomal circular DNA as a biomarker in EGFR-targeted therapy of non-small cell lung cancer.
- 30 Oct 2025
- Molecular oncology
A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications.
- 29 Oct 2025
- Molecular oncology
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies.
- 29 Oct 2025
- Molecular oncology
In vitro models of cancer-associated fibroblast heterogeneity uncover subtype-specific effects of CRISPR perturbations.
- 27 Oct 2025
- Molecular oncology
Aggressive prostate cancer is associated with pericyte dysfunction.
- 21 Oct 2025
- Molecular oncology
CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation.
- 17 Oct 2025
- Molecular oncology
Plasma extrachromosomal circular DNA as a biomarker in EGFR-targeted therapy of non-small cell lung cancer.
- 30 Oct 2025
- Molecular oncology
A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications.
- 29 Oct 2025
- Molecular oncology
The rapidly growing landscape of RAS inhibitors: from selective allele blockade to broad inhibition strategies.
- 29 Oct 2025
- Molecular oncology
In vitro models of cancer-associated fibroblast heterogeneity uncover subtype-specific effects of CRISPR perturbations.
- 27 Oct 2025
- Molecular oncology
Aggressive prostate cancer is associated with pericyte dysfunction.
- 21 Oct 2025
- Molecular oncology
CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation.
- 17 Oct 2025
- Molecular oncology
FAQs on Molecular Oncology
How long has Molecular Oncology been actively publishing? 
What is the publishing frequency of Molecular Oncology?
How many articles did Molecular Oncology publish last year?
What is the eISSN & pISSN for Molecular Oncology?
What is Citescore for Molecular Oncology?
What is the H Index for Molecular Oncology ?
What is SNIP score for Molecular Oncology?
What is the SJR for Molecular Oncology?
Who is the publisher of Molecular Oncology?
